Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q3 2022 Earnings Conference Call November 9, 2022 11:30 AM ET Company Participants Julie Tepper - Investor Relations Brett Monia - Founder, CEO & Director Richard Geary - EVP & Chief Development Officer Elizabeth Hougen - EVP, Finance & CFO Eric Swayze - EVP, Research Eugene Schneider - EVP & Chief Clinical Development Officer Onaiza Cadoret - EVP, Chief Global Product Strategy & Operations Officer Conference Call Participants Gary Nachman - BMO Capital Markets Yana ...

IONIS | --- | --- | --- | --- | --- | |------------------|-------|-------|-------|-------| | | | | | | | November 9, 2022 | | | | | | Nasdaq: IONS | | | | | | | | | | | On Today's Earnings Call 2 Brett Monia, Ph.D. Chief Executive Officer Richard Geary, Ph.D. Executive Vice President, Development Beth Hougen Chief Financial Officer Eric Swayze, Ph.D. Executive Vice President, Research Eugene Schneider, M.D. Executive Vice President, Chief Clinical Development Officer Onaiza Cadoret Executive Vice President, ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2022 Earnings Conference Call August 9, 2022 11:30 AM ET Company Participants Brett Monia - Chief Executive Officer Beth Hougen - Chief Financial Officer Richard Geary - Executive Vice President of Development Eric Swayze - Executive Vice President of Research Eugene Schneider - Chief Clinical Development Officer Onaiza Cadoret - Chief Global Product Strategy & Operations Officer Conference Call Participants Yanan Zhu - Wells Fargo Jessica Fye - JPMorgan Do Kim - ...

IONIS | --- | --- | --- | --- | --- | |----------------|-------|-------|-------|-------| | | | | | | | August 9, 2022 | | | | | | Nasdaq: IONS | | | | | | | | | | | On Today's Earnings Call 2 Brett Monia, Ph.D. Chief Executive Officer Beth Hougen Chief Financial Officer Richard Geary, Ph.D. Executive Vice President, Development Eric Swayze, Ph.D. Executive Vice President, Research Eugene Schneider, M.D. Executive Vice President, Chief Clinical Development Officer Onaiza Cadoret Executive Vice President, Chi ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2022 Earnings Conference Call May 4, 2022 11:30 AM ET Company Participants Brett Monia - Founder, CEO & Director Elizabeth Hougen - EVP, Finance & CFO Eugene Schneider - EVP & Chief Clinical Development Officer Eric Swayze - EVP, Research Onaiza Cadoret - EVP and Chief Product Strategy & Operations Officer Conference Call Participants Yanan Zhu - Wells Fargo Securities Brendan Smith - Cowen and Company Luca Issi - RBC Capital Markets Jessica Fye - JPMorgan Chase ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2021 Results Earnings Conference Call February 24, 2022 11:30 AM ET Company Participants Jennifer Capuzelo - Director of Investor Relation Brett Monia - Founder & CEO Beth Hougen - Chief Financial Officer Richard Geary - Executive Vice President & Chief Development Officer Eric Swayze - Executive Vice President of Research Onaiza Cadoret-Manier - Executive Vice President & Chief Product Strategy & Operations Officer Conference Call Participants Gary Nachman - BMO ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q3 2021 Earnings Conference Call November 3, 2021 11:30 AM ET Company Participants Jennifer Capuzela - Director of Investor Relation Brett Monia - Founder, CEO & Director Beth Hougen - Chief Financial Officer Richard Geary - EVP & Chief Development Officer Onaiza Cadoret-Manier - EVP and Chief Corporate Development & Commercial Officer Eric Swayze - EVP of Research Conference Call Participants Yale Jen - Laidlaw & Co Chi Meng Fong - BofA Securities Yanan Zhu - Wells ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2021 Earnings Conference Call August 4, 2021 11:30 AM ET Company Participants David Nakasone - IR Brett Monia - Founder, CEO & Director Elizabeth Hougen - EVP, Finance & CFO Richard Geary - EVP & Chief Development Officer Eric Swayze - EVP, Research Onaiza Cadoret-Manier - EVP & Chief Corporate Development & Commercial Officer Conference Call Participants Jason Gerberry - Bank of America Merrill Lynch Luca Issi - RBC Capital Markets Brendan Smith - Cowen and Comp ...

| --- | --- | --- | --- | --- | --- | |------------------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2021 Annual Meeting of | | | | | | | Stockholders Corporate | | | | | | | Presentation | | | | | | | June 2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Changes to the Ionis Board of Directors (1 of 2) 2 Departures Stanley T. Crooke, M.D., Ph.D. Ionis Founder and Executive Chairman 30 Years of ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2021 Earnings Conference Call May 5, 2021 11:30 AM ET Company Participants Wade Walke - VP, IR Brett Monia - CEO Beth Hougen - CFO Richard Geary - EVP of Development Eric Swayze - EVP of Research Onaiza Cadoret - Chief Corporate Development and Commercial Officer Conference Call Participants Luca Issi - RBC Yaron Werber - Cowen Yanan Zhu - Wells Fargo Yale Jen - Laidlaw and Company Jason Gerberry - Bank of America Jessica Fye - JP Morgan Mani Foroohar - SVB Leeri ...